Auwaerter on Infectious Diseases

Paul G. Auwaerter, MD, MBA, has disclosed no relevant financial relationships. Dr. Auwaerter is a paid consultant to Medscape, and his participation and contributions do not constitute endorsement by The Johns Hopkins University, Hospital, or Health System.
- Paxlovid Rebound: What Is Happening?
2
- A Surprising Cause of Abdominal Pain and Other GI Symptoms
9
- Is the Epstein-Barr Virus Associated With COVID-19?
11
- Treatment Considerations for Pregnant Women With COVID-19
- A Quick Tour of the New Lyme Disease Guideline
7
- COVID-19: Updated Mask Guidance From the CDC
3
- Monoclonals for COVID-19 a 'Minor Contribution'
5
- SARS-CoV-2 Diagnostics, From Serology to Spit
1
- 'Warning Lights' Ahead: Insights From COVID Epidemiology
- Highlights From IDWeek 2020: Fauci on COVID-19
- 'No One Is Protected' From COVID-19, Not Even the President
5
- This 'Slowly Evolving Crisis' Needs Attention
- Cases Are Up, Mask Use Is Down -- Let's Reverse That
27
- 'Thinnest Threads of Evidence' for COVID-19 Treatments
138
- Coronaviruses: What We Know Now
5
- Infectious Diseases in 2020: 5 Areas of Concern
3
- Auwaerter's Highlights From IDWeek 2019
1
- Lyme Testing Gets Fast and Easy
27
- Will This Be the Holy Grail for Sepsis?
5
- Severe Malaria: Only One Drug Option Remains
5